Romano Di Fabio

2.5k citations

104 papers · 1.7k indexed · h-index 24

Organic Chemistry top 2%
Molecular Biology
Cellular and Molecular Neuroscience top 5%
Endocrine and Autonomic Systems top 5%
Pharmacology top 10%

Co-authors: Giuseppe Alvaro Daniele Donati Carlo Bonini Fabrizio Micheli Tino Rossi Mauro Corsi Stephen Hanessian Emiliangelo Ratti
Topics: Neuroscience and Neuropharmacology Research (26 papers)Chemical Synthesis and Analysis (21 papers)Receptor Mechanisms and Signaling (21 papers)
Cited by: Organic Chemistry Endocrine and Autonomic Systems Cellular and Molecular Neuroscience
Journals: Journal of Medicinal Chemistry Science Advances Journal of Hepatology
Partner nations: Italy United Kingdom United States

In The Last Decade

Romano Di Fabio

98 papers receiving 1.5k citations

Peers

Countries citing papers authored by Romano Di Fabio

Since Specialization

Citations

This map shows the geographic impact of Romano Di Fabio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Romano Di Fabio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Romano Di Fabio more than expected).

Fields of papers citing papers by Romano Di Fabio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Romano Di Fabio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Romano Di Fabio. The network helps show where Romano Di Fabio may publish in the future.

Co-authorship network of co-authors of Romano Di Fabio

This figure shows the co-authorship network connecting the top 25 collaborators of Romano Di Fabio. A scholar is included among the top collaborators of Romano Di Fabio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Romano Di Fabio. Romano Di Fabio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prdm16-mediated H3K9 methylation controls fibro-adipogenic progenitors identity during skeletal muscle repair 2021 ·Science Advances ·(unknown),(unknown),Daniel Fernández-Pérez,(unknown),Fabrizia Marullo,Roberta Maggio,Tiziana Santini,(unknown),Stefano Biagioni,Vincenzo Summa,Carlo Toniatti,Diego Pasini,Sigmar Stricker,Romano Di Fabio,Fulvio Chiacchiera,Giovanna Peruzzi,Chiara Mozzetta	44
2	Stereocontrolled synthesis of 5-azaspiro[2.3]hexane derivatives as conformationally “frozen” analogues of L-glutamic acid 2014 ·Beilstein Journal of Organic Chemistry ·Beatrice Bechi,David Amantini,Cristina Tintori,Maurizio Botta,Romano Di Fabio	7
3	Identification, biological characterization and pharmacophoric analysis of a new potent and selective NK1 receptor antagonist clinical candidate 2013 ·Bioorganic & Medicinal Chemistry ·Romano Di Fabio,Giuseppe Alvaro,Simone Braggio,Renzo Carletti,Philip Gerrard,Cristiana Griffante,Carla Marchioro,Alfonso Pozzan,Sergio Melotto,(unknown),Laura Piccoli,Emiliangelo Ratti,(unknown),Michael K. Trower,Simone Spada,Mauro Corsi	19
4	Functional and binding kinetic studies make a distinction between OX1 and OX2 orexin receptor antagonists 2012 ·European Journal of Pharmacology ·(unknown),(unknown),Marinella Antolini,Romano Di Fabio,Emilio Merlo Pich,Mauro Corsi	18
5	Azabicyclo[3.1.0]hexane‐1‐carbohydrazides as Potent and Selective GHSR1a Ligands Presenting a Specific in vivo Behavior 2011 ·ChemMedChem ·Fabio Maria Sabbatini,Sergio Melotto,Giovanni Bernasconi,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Laura Zonzini,Vivian J. A. Costantini,(unknown),Enzo Valerio,Alfonso Pozzan,(unknown),(unknown),Mauro Corsi,Romano Di Fabio	7
6	Pyrrolo[1,2-a]pyrazine and pyrazolo[1,5-a]pyrazine: Novel, potent, and selective series of Vasopressin1b receptor antagonists 2010 ·Bioorganic & Medicinal Chemistry Letters ·Roberto Arban,Federica Bianchi,Alberto Buson,(unknown),Romano Di Fabio,Gabriella Gentile,Fabrizio Micheli,(unknown),Alfonso Pozzan,Luca Tarsi,Silvia Terreni,(unknown)	34
7	Discovery and structure–activity relationship of a novel spirocarbamate series of NPY Y5 antagonists 2010 ·Bioorganic & Medicinal Chemistry Letters ·Colin P. Leslie,Jonathan Bentley,Matteo Biagetti,(unknown),Romano Di Fabio,Daniele Donati,(unknown),Sébastien Guery,(unknown),(unknown),(unknown),(unknown),Catia Seri,Michela Tessari,Laura Zonzini,Laura Caberlotto	5
8	Dopamine D3 receptor antagonists: The quest for a potentially selective PET ligand. Part one: Lead identification 2009 ·Bioorganic & Medicinal Chemistry Letters ·Ian P. Holmes,Fabrizio Micheli,(unknown),Olivier Lorthioir,Steve P. Watson,Romano Di Fabio,Gabriella Gentile,Christian Heidbreder,(unknown),Angela Worby	9
9	Phenylethynyl-pyrrolo[1,2-a]pyrazine: A new potent and selective tool in the mGluR5 antagonists arena 2008 ·Bioorganic & Medicinal Chemistry Letters ·Fabrizio Micheli,Barbara Bertani,(unknown),Luca Crippa,Paolo Cavanni,Romano Di Fabio,Daniele Donati,(unknown),(unknown),Alfredo Paio,(unknown),Paola Zarantonello	27
10	New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems 2008 ·Bioorganic & Medicinal Chemistry Letters ·Fabrizio Micheli,Giorgio Bonanomi,Simone Braggio,Anna Maria Capelli,(unknown),(unknown),Romano Di Fabio,Daniele Donati,Stefania Gagliardi,Gabriella Gentile,Dieter Hamprecht,Marcella Petrone,Stefano Radaelli,Giovanna Tedesco,Silvia Terreni,Angela Worby,Christian Heidbreder	21
11	From pyrroles to 1-oxo-2,3,4,9-tetrahydro-1H-β-carbolines: A new class of orally bioavailable mGluR1 antagonists 2007 ·Bioorganic & Medicinal Chemistry Letters ·Romano Di Fabio,Fabrizio Micheli,Giuseppe Alvaro,Paolo Cavanni,Daniele Donati,(unknown),Gabriele Fontana,Riccardo Giovannini,(unknown),(unknown),(unknown),Giovanni Vitulli	26
12	Novel carbazole derivatives as NPY Y1 antagonists 2006 ·Bioorganic & Medicinal Chemistry Letters ·Colin P. Leslie,Romano Di Fabio,(unknown),(unknown),Simone Braggio,(unknown),Daniele Donati,(unknown),(unknown),Riccardo Giovannini,(unknown),Angelo Pecunioso,(unknown),(unknown),(unknown),Luigi Stasi	15
13	Chiral tetrahydroquinoline derivatives as potent anti-hyperalgesic agents in animal models of sustained inflammation and chronic neuropathic pain 2006 ·Bioorganic & Medicinal Chemistry Letters ·Romano Di Fabio,Giuseppe Alvaro,Barbara Bertani,Daniele Donati,(unknown),Gabriella Gentile,(unknown),(unknown),Simone Spada,Emiliangelo Ratti,Mauro Corsi,M. Quartaroli,Robert J. Barnaby,Giovanni Vitulli	21
14	From pyrroles to pyrrolo[1,2-a]pyrazinones: A new class of mGluR1 antagonists 2005 ·Bioorganic & Medicinal Chemistry Letters ·Fabrizio Micheli,Paolo Cavanni,Romano Di Fabio,Carla Marchioro,Daniele Donati,(unknown),(unknown),Fabio Maria Sabbatini,(unknown)	10
15	Synthesis and biological evaluation of pro-drugs of GW196771, a potent glycine antagonist acting at the NMDA receptor 2005 ·Il Farmaco ·Angela Angusti,Elisa Durini,Silvia Vertuani,Alessandro Dalpiaz,(unknown),Romano Di Fabio,Daniele Donati,(unknown),Giovanni Vitulli,Robert J. Barnaby,Stefano Manfredini	3
16	3-Methyl pyrrole-2,4-dicarboxylic acid 2-propyl ester 4-(1,2,2-trimethyl-propyl) ester: an exploration of the C-2 position. Part I 2004 ·Il Farmaco ·Fabrizio Micheli,Romano Di Fabio,(unknown),Anna Maria Capelli,(unknown),Paolo Cavanni,(unknown),Daniele Donati,Aldo Feriani,(unknown),Mahmoud Hamdan,(unknown),Fabio Maria Sabbatini,(unknown),(unknown)	17
17	Enantiomerically pure tetrahydroquinoline derivatives as in vivo potent antagonists of the glycine binding site associated to the NMDA receptor 2003 ·Bioorganic & Medicinal Chemistry Letters ·Romano Di Fabio,(unknown),Barbara Bertani,Giuseppe Alvaro,Fabrizio Micheli,Fabio Maria Sabbatini,(unknown),(unknown),(unknown),(unknown),Daniele Donati,Emiliangelo Ratti,Roberto Arban,(unknown),Angelo Reggiani,Robert J. Barnaby	20
18	2,4-Dicarboxy-pyrroles as selective non-competitive mGluR1 antagonists: an exploration of the role of the pyrrolic scaffold 2003 ·Il Farmaco ·Fabrizio Micheli,Romano Di Fabio,Paolo Cavanni,Daniele Donati,(unknown),(unknown),(unknown),Carla Marchioro,Fabio Maria Sabbatini,Giorgio Tarzia,(unknown),(unknown)	5
19	A new alternative synthesis of 5-cyanophthalide, a versatile intermediate in the preparation of the antidepressant drug citalopram 2001 ·Il Farmaco ·Fabrizio Micheli,Luca Crippa,Daniele Donati,Romano Di Fabio,Colin P. Leslie	1
20	New Synthesis of Substituted 2-Carboxyindole Derivatives: Versatile Introduction of a Carbamoylethynyl Moiety at the C-3 Position 1999 ·Archiv der Pharmazie ·(unknown),Romano Di Fabio,(unknown),(unknown),(unknown),Fabrizio Micheli,(unknown)	11

About Romano Di Fabio

Romano Di Fabio is a scholar working on Cellular and Molecular Neuroscience, Organic Chemistry and Behavioral Neuroscience, having authored 104 papers that have together received 1.7k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (26 papers), Chemical Synthesis and Analysis (21 papers) and Receptor Mechanisms and Signaling (21 papers). The work is most often cited by research in Organic Chemistry (900 citations), Endocrine and Autonomic Systems (142 citations) and Cellular and Molecular Neuroscience (336 citations). Romano Di Fabio has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Giuseppe Alvaro, Daniele Donati, Carlo Bonini, Fabrizio Micheli, Tino Rossi, Mauro Corsi, Stephen Hanessian, Emiliangelo Ratti, Francesco Bonadies and Andrea Gualandi. Their work appears in journals such as Journal of Medicinal Chemistry, Science Advances and Journal of Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact